Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation

Journal of Experimental Medicine

Volumn 190, Issue 3, 1999, Pages 375-384

  Holdorf, Amy D ^a   Green, Jonathan M ^a   Levin, Steven D ^b   Denny, Michael F ^c   Straus, David B ^c   Link, Vinzenz ^a   Changeliank, Paul S ^d   Allen, Paul M ^a   Shaw, Andrey S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

CD28; Costimulation; Lck; SH3 domain; Tyrosine kinase

Indexed keywords

CD2 ANTIGEN; CD28 ANTIGEN; MEMBRANE PROTEIN; PROLINE; PROTEIN KINASE P60; T LYMPHOCYTE RECEPTOR;

ARTICLE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; SEQUENCE HOMOLOGY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0033517125     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.3.375     Document Type: Article

References (49)

1. Cartwright, C.A., W. Eckhart, S. Simon, and P.L. Kaplan. 1987. Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain. Cell. 49:83-91.
2. Kmiecik, T.E., and D. Shalloway. 1987. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell. 49:65-73.
3. Piwnica-Worms, H., K.B. Saunders, T.M. Roberts, A.E. Smith, and S.H. Cheng. 1987. Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell. 49:75-82.
4. McFarland, E.D., T.R. Hurley, J.T. Pingel, B.M. Sefton, A. Shaw, and M.L. Thomas. 1993. Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor. Proc. Natl. Acad. Sci. USA. 90:1402-1406.
5. Ostergaard, H.L., and I.S. Trowbridge. 1990. Coclustering CD45 with CD4 or CD8 alters the phosphorylation and kinase activity of p56lck. J. Exp. Med. 172:347-350.
6. Sicheri, F., I. Moarefi, and J. Kuriyan. 1997. Crystal structure of the Src family tyrosine kinase Hck. Nature. 385:602-609.
7. Xu, W., S.C. Harrison, and M.J. Eck. 1997. Three-dimensional structure of the tyrosine kinase c-Src. Nature. 385:595-602.
8. Moarefi, I., B.M. LaFevre, F. Sicheri, M. Huse, C.H. Lee, J. Kuriyan, and W.T. Miller. 1997. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature. 385:650-653.
9. Briggs, S.D., M. Sharkey, M. Stevenson, and T.E. Smithgall. 1997. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J. Biol. Chem. 272:17899-17902.
10. Alexandropoulos, K., and D. Baltimore. 1996. Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin. Genes Dev. 10:1341-1355.
11. Lorenz, R.G., A.N. Tyler, and P.M. Allen. 1989. Reconstruction of the immunogenic peptide RNase(43-56) by identification and transfer of the critical residues into an unrelated peptide backbone. J. Exp. Med. 170:203-215.
12. Green, J.M., P.J. Noel, A.I. Sperling, T.L. Walunas, G.S. Gray, J.A. Bluestone, and C.B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity. 1:501-508.
13. Ren, R., B.J. Mayer, P. Cicchetti, and D. Baltimore. 1993. Identification of a ten-amino acid proline-rich SH3 binding site. Science. 259:1157-1161.
14. Feng, S., J.K. Chen, H. Yu, J.A. Simon, and S.L. Schreiber. 1994. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science. 266:1241-1247.
15. August, A., and B. Dupont. 1994. Activation of src family kinase lck following CD28 crosslinking in the Jurkat leukemic cell line. Biochem. Biophys. Res. Commun. 199:1466-1473.
16. Bell, G.M., J.B. Bolen, and J.B. Imboden. 1992. Association of Src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells. Mol. Cell. Biol. 12:5548-5554.
17. Bell, G.M., J. Fargnoli, J.B. Bolen, L. Kish, and J.B. Imboden. 1996. The SH3 domain of p56lck binds to proline-rich sequences in the cytoplasmic domain of CD2. J. Exp. Med. 183:169-178.
18. Lin, H., J.E. Hutchcroft, C.E. Andoniou, M. Kamoun, H. Band, and B.E. Bierer. 1998. Association of p59(fyn) with the T lymphocyte costimulatory receptor CD2. Binding of the Fyn Src homology (SH) 3 domain is regulated by the Fyn SH2 domain. J. Biol. Chem. 273:19914-19921.
19. June, C.H., J.A. Bluestone, L.M. Nadler, and C.B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today. 15:321-331.
20. Rudd, C.E. 1996. Upstream-downstream: CD28 cosignaling pathways and T cell function. Immunity. 4:527-534.
21. Shibuya, H., K. Kohu, K. Yamada, E.L. Barsoumian, R.M. Perlmutter, and T. Taniguchi. 1994. Functional dissection of p56lck, a protein tyrosine kinase which mediates interleukin-2-induced activation of the c-fos gene. Mol. Cell. Biol. 14: 5812-5819.
22. Denny, M.F., H.C. Kaufman, A.C. Chan, and D.B. Straus. 1999. The Lck SH3 domain is required for activation of the MAP kinase pathway, but not the initiation of TCR signaling. J. Biol. Chem. 274:5146-5152.
23. Straus, D.B., and A. Weiss. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell. 70:585-593.
24. Molina, T.J., K. Kishihara, D.P. Siderovski, W. van Ewijk, A. Narendran, E. Timms, A. Wakeham, C.J. Paige, K.U. Hartmann, A. Veillette, et al. 1992. Profound block in thymocyte development in mice lacking p56lck. Nature. 357:161-164.
25. Shaw, A.S., and M.L. Dustin. 1997. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity. 6:361-369.
26. Dustin, M.L., D.E. Golan, D.M. Zhu, J.M. Miller, W. Meier, E.A. Davies, and P.A. van der Merwe. 1997. Low affinity interaction of human or rat T cell adhesion molecule CD2 with its ligand aligns adhering membranes to achieve high physiological affinity. J. Biol. Chem. 272:30889-30898.
27. Danielian, S., A. Alcover, L. Polissard, M. Stefanescu, O. Acuto, S. Fischer, and R. Fagard. 1992. Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck. CD2 can mediate TcR-CD3-independent and CD45-dependent activation of p56lck. Eur. J. Immunol. 22:2915-2921.
28. Gibson, S., K. Truitt, Y. Lu, R. Lapushin, H. Khan, J.B. Imboden, and G.B. Mills. 1998. Efficient CD28 signalling leads to increases in the kinase activities of the TEC family tyrosine kinase EMT/ITK/TSK and the SRC family tyrosine kinase LCK. Biochem. J. 330:1123-1128.
29. Luo, K.X., and B.M. Sefton. 1990. Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine protein kinase at the autophosphorylation site. Mol. Cell. Biol. 10:5305-5313.
30. Tsygankov, A.Y., C. Spana, R.B. Rowley, R.C. Penhallow, A.L. Burkhardt, and J.B. Bolen. 1994. Activation-dependent tyrosine phosphorylation of Fyn-associated proteins in T lymphocytes. J. Biol. Chem. 269:7792-7800.
31. Yu, H., J.K. Chen, S. Feng, D.C. Dalgarno, A.W. Brauer, and S.L. Schreiber. 1994. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell. 76:933-945.
32. Pages, F., M. Ragueneau, S. Klasen, M. Battifora, D. Couez, R. Sweet, A. Truneh, S.G. Ward, and D. Olive. 1996. Two distinct intracytoplasmic regions of the T-cell adhesion molecule CD28 participate in phosphatidylinositol 3-kinase association. J. Biol. Chem. 271:9403-9409.
33. Shapiro, V.S., K.E. Truitt, J.B. Imboden, and A. Weiss. 1997. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol. Cell. Biol. 17:4051-4058.
34. Olszowy, M.W., P.L. Leuchtmann, A. Veillette, and A.S. Shaw. 1995. Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines. J. Immunol. 155:4236-4240.
35. Stein, P.H., J.D. Fraser, and A. Weiss. 1994. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3′-kinase. Mol. Cell. Biol. 14:3392-3402.
36. King, P.D., A. Sadra, J.M. Teng, R.L. Xiao, A. Han, A. Selvakumar, A. August, and B. Dupont. 1997. Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK. J. Immunol. 158:580-590.
37. Sadra, A., T. Cinek, J.L. Arellano, J. Shi, K.E. Truitt, and J.B. Imboden. 1999. Identification of tyrosine phosphorylation sites in the CD28 cytoplasmic domain and their role in the costimulation of Jurkat T cells. J. Immunol. 162:1966-1973.
38. Harding, F.A., J.G. McArthur, J.A. Gross, D.H. Raulet, and J.P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature. 356:607-609.
39. Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neriah. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell. 77:727-736.
40. Bryan, R.G., Y. Li, J.H. Lai, M. Van, N.R. Rice, R.R. Rich, and T.H. Tan. 1994. Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells. Mol. Cell. Biol. 14:7933-7942.
41. κB family: c-Rel, p50, and p65. Proc. Natl. Acad. Sci. USA. 90:1696-1700.
42. August, A., S. Gibson, Y. Kawakami, T. Kawakami, G.B. Mills, and B. Dupont. 1994. CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc. Natl. Acad. Sci. USA. 91:9347-9351.
43. Klasen, S., F. Pages, J.F. Peyron, D.A. Cantrell, and D. Olive. 1998. Two distinct regions of the CD28 intracytoplasmic domain are involved in the tyrosine phosphorylation of Vav and GTPase activating protein-associated p62 protein. Int. Immunol. 10:481-489.
44. Nunes, J.A., A. Truneh, D. Olive, and D.A. Cantrell. 1996. Signal transduction by CD28 costimulatory receptor on T cells. B7-1 and B7-2 regulation of tyrosine kinase adaptor molecules. J. Biol. Chem. 271:1591-1598.
45. Atluru, S., and D. Atluru. 1991. Evidence that genistein, a protein-tyrosine kinase inhibitor, inhibits CD28 monoclonal-antibody-stimulated human T cell proliferation. Transplantation. 51:448-450.
46. June, C.H., J.A. Ledbetter, M.M. Gillespie, T. Lindsten, and C.B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biology. 7:4472-4481.
47. Wulfing, C., and M.M. Davis. 1998. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science. 282:2266-2269.
48. Viola, A., S. Schroeder, Y. Sakakibara, and A. Lanzavecchia. 1999. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science. 283:680-682.
49. Dustin, M.L., and A.S. Shaw. 1999. Costimulation: building an immunological synapse. Science. 283:649-650.